Parisi Gray Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Parisi Gray Wealth Management's MRNA Position: Q1 2023 in Review
Parisi Gray Wealth Management sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,437 shares — an estimated $258K sold.
Parisi Gray Wealth Management first reported a position in MRNA in Q2 2021 and held it in 5 quarters. The position peaked at $412K in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.
- Parisi Gray Wealth Management reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
- Parisi Gray Wealth Management sold 1,437 Moderna shares in Q1 2023, an estimated $258K.
- Parisi Gray Wealth Management first reported a position in Moderna in Q2 2021 and held it in 5 quarters.
- Parisi Gray Wealth Management's Moderna position peaked at $412K in Q3 2021.
- 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.
Based on Parisi Gray Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.